1
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:September 16, 2019Terminated
Neovascularization, Pathologic: 1064 Clinical Trials, Page 1 of 107
Hide Studies Not Open or Pending
2
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
Condition(s):Pressure Ulcer; Bedsore; Spinal Cord Injury; ParaplegiaLast Updated:May 22, 2018Recruiting
3
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
Condition(s):Corneal Neovascularization; Corneal Graft Failure; Anterior Segment InflammationLast Updated:August 5, 2016Withdrawn
4
The Effect of Bevacizumab on Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:December 2, 2011Completed
5
Strategies for Management of Corneal Neovascularisation
Condition(s):Corneal NeovascularisationLast Updated:December 2, 2015Unknown status
6
Bevacizumab for the Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:October 15, 2009Unknown status
7
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:November 8, 2007Completed
8
68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Condition(s):Pathological AngiogenesisLast Updated:November 15, 2016Unknown status
9
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:July 22, 2013Completed
10
Treatment of Corneal Neovascularization With Topical Pazopanib
Condition(s):Corneal NeovascularizationLast Updated:January 18, 2018Completed